
Syantra
ClaimedA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
About
Syantra is a precision biotechnology company focused on revolutionizing cancer detection and treatment. Their proprietary Onco-ID™ platform utilizes a blood-based liquid biopsy to detect early signs of cancer by analyzing shifts in the body's immune system and physiological responses, rather than directly looking for cancer cells. This approach aims to enable earlier diagnosis and more effective interventions.
Also in this space
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, MedTech
AI-powered biotechnology company developing RNA therapeutics for genetic diseases.
Shares Biotech, Drug Discovery
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Shares Biotech, MedTech
NewLimit is developing epigenetic therapies to extend human healthspan by reprogramming aging cells.
Shares Biotech, Drug Discovery
Developing engineered biologics to harness the immune system for disease treatment.
Shares Biotech, Drug Discovery
Key facts
- Website
- syantra.ca
- Headquarters
- Calgary, Canada
- Founded
- 2016
- Employees
- 14
- Total funding
- $4M (Series A-1)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 11 Sept 2024 | Series A-1 | $4M |
Test your Agent Readiness
How well ChatGPT, Claude and the other agents can read and use a site. About a minute.
Frequently asked
Is Syantra trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Syantra is 51 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Syantra raised?
Syantra has raised a total of $4M in funding. The most recent round on record is Series A-1.
How many employees does Syantra have?
Syantra has approximately 14 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Syantra:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

